Optimal Imaging Modalities for Today’s Practice in Ultrasound-Enhanced Echocardiography – CME

Current Status
Not Enrolled
Price
Closed
Get Started

Clinicians have shown a growing interest in CEUS for diagnostic use and treatment monitoring in the clinical setting, due to new indications and the expansion of CEUS subjective and objective analytical capabilities. Therefore, there is a need to provide up to date information to clinicians on Clinical use of Ultrasonic Enhancing Agents (UEAs) in Echocardiography. Additionally, UEAs and Low Mechanical Index techniques will be explored with emphasis on how to implement these techniques in everyday practice.

  1. Discuss Clinical use of Ultrasonic Enhancing Agents (UEAs) in
    Echocardiography.
  2. Describe UEAs and Low Mechanical Index Modalities.
  3. Discuss How Ultrasound Interacts with Microbubbles to Produce Signal.

The content of this CME webinar is intended for healthcare professionals including Cardiologists, Echocardiographers and Other Physicians, Sonographers, Imaging Nurses, Administrators, Researchers, and Others.

Physicians: The Northwest Imaging Forums is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Northwest Imaging Forums designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

All CME course participants are required to pass an online test with a minimum score of 70% in order to be awarded credit.  All CME course participants will also have the opportunity to critically evaluate the program as it relates to practice relevance and educational objectives.

AMA PRA Category 1 Credit(s)TM for these programs may be claimed until September 15, 2020.
This CME activity was planned and produced by The Northwest Imaging Forums.
This CME activity was planned and produced in accordance with the ACCME Essential Areas and Elements.

Release Date: 9/19/2019 | Expires: 9/18/2020

AVAILABLE CREDIT

1.0 AMA PRA Category 1 Credit™

 

Dr. Michelle Bierig, PhD, ACS, RDCS, RDMS, RCS, CPHQ, FSDMS, FASE, AACC reported no relevant relationships with entities producing health care goods or services.

Dr. Thomas R. Porter, MD, FACC, FASE has financial interests with the following entity or entities producing health care goods or services as indicated below:

  • Philips Healthcare


Dr. Sanjiv Kaul, MD, FACC, FASE, FAHA, FRCP
has financial interests with the following entity or entities producing health care goods or services as indicated below:

  • Bracco Diagnostics, Inc
  • Ultromics

 

All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above.  No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.